Treatment for severe acute respiratory distress syndrome from COVID-19
- PMID: 32203709
- PMCID: PMC7118607
- DOI: 10.1016/S2213-2600(20)30127-2
Treatment for severe acute respiratory distress syndrome from COVID-19
Figures
Comment in
-
COVID-19: Respiratory support outside the intensive care unit.Lancet Respir Med. 2020 Jun;8(6):538-539. doi: 10.1016/S2213-2600(20)30176-4. Epub 2020 Apr 9. Lancet Respir Med. 2020. PMID: 32278367 Free PMC article. No abstract available.
-
Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far?Perfusion. 2020 Sep;35(6):558-561. doi: 10.1177/0267659120934279. Epub 2020 Jun 24. Perfusion. 2020. PMID: 32579068 No abstract available.
Comment on
-
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.Lancet Respir Med. 2020 May;8(5):518-526. doi: 10.1016/S2213-2600(20)30121-1. Epub 2020 Mar 20. Lancet Respir Med. 2020. PMID: 32203711 Free PMC article. Review.
References
-
- Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965–1975. - PubMed
-
- Frat J-P, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–2196. - PubMed
-
- WHO Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://apps.who.int/iris/rest/bitstreams/1266296/retrieve
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
